PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced today...
Genome Perspective provides an innovative human/AI hybrid solution to rapidly accelerate project brief creation and bypass mundane, repetitive aspects of the process
TORONTO & NEW...
In 1970, a groundbreaking discovery unfolded within the hallowed halls of the University of Oxford as researchers delving into cannabis stumbled upon a chemical...
Novo Nordisk is deepening its investment in cardiometabolic disease drug development, this time with a partnership with German biotech Evotec.
The companies announced Tuesday a new...
RIDGEFIELD, Conn. and INDIANAPOLIS, Sept. 22, 2023 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Jardiance® (empagliflozin) 10 mg tablets to...
Pictured: People in suits with their thumbs down/iStock, iammotos The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee on Thursday unanimously voted against Intarcia Therapeutics’...
September is Polycystic Ovary Syndrome (PCOS) Awareness Month, dedicated to spreading knowledge on this common yet often misunderstood health condition. PCOS affects millions of...